retatrutide clinical trial data Results: 24% Weight Loss in 48 Weeks retatrutide dosing schedule clinical trial
Description
The key difference between the two medications is that Ozempic (Wegovy) is single action and mimics a hormone that targets one receptor in the body
These GLP-1 receptor agonists signal to the brain that you are full, slow down digestion, and help stabilize blood sugar levels
It contains tirzepatide, a medication that acts on GLP-1 and GIP receptors to regulate appetite and glucose metabolism
Xenical - orlistat capsule
GIP activation enhances insulin sensitivity and appears to reduce the GI side effects commonly associated with pure GLP-1 agonists
That is why ongoing communication with your provider matters
